MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Weight loss is associated with rapid striatal dopaminergic degeneration in Parkinson’s disease

KJ. Pak, HK. Shin, EJ. Kim, JH. Lee, CH. Lyoo, JS. Son, MJ. Lee, HJ. Son (Busan, Republic of Korea)

Meeting: 2018 International Congress

Abstract Number: 1605

Keywords: Parkinsonism, Single-photon emission computed tomography(SPECT)

Session Information

Date: Monday, October 8, 2018

Session Title: Parkinson's Disease: Non-Motor Symptoms

Session Time: 1:15pm-2:45pm

Location: Hall 3FG

Objective: To investigate whether weight loss has a longitudinal association with striatal dopaminergic degeneration in Parkinson’s disease (PD).

Background: Weight loss in PD is associated with poorer clinical outcomes and rapid disease progression [1,2]. However, it is unclear whether a longitudinal association between weight loss and striatal dopaminergic degeneration exists.

Methods: Using data from 171 PD patients in the Parkinson’s Progression Markers Initiative (PPMI) cohort, we investigated longitudinal associations of change in body mass index (BMI) with striatal dopaminergic activity on 123I-N-3-fluoropropyl-2-beta-carboxymethoxy-3beta-(4-iodophenyl) nortropane (123I-FP-CIT) single positron emission computed tomography (SPECT). We defined BMI loss as a reduction in BMI value > 5% of baseline, and categorized the PD patients into 2 subgroups (patients with and without BMI loss). Linear mixed model (LMM) analysis was employed to compare the progression of striatal dopaminergic degeneration.

Results: In LMM analyses, BMI values in PD patients were not correlated with clinical severities of parkinsonian motor deficits, cognitive impairment and depressive mood. However, BMI values were positively associated with changes in striatal 123I-FP-CIT binding over 24 months (caudate nucleus, estimate = 9.37 x 10-^3, p = 0.009; putamen, estimate= 7.04 x 10^-3, p 0.031). Patients with BMI loss exhibited greater deterioration of striatal dopaminergic activity than those without (caudate nucleus, estimate = 3.35 x 10^-3, p = 0.008; putamen, estimate = 2.34 x 10^-3, p = 0.025).

Conclusions: Our findings suggest a potential association between striatal dopaminergic activity with body weight or impairment in energy homeostasis. Body weight and its change may be a clinical biomarker reflecting striatal dopaminergic dysfunction in PD.

References: [1] H. Chen, S.M. Zhang, M.A. Hernan, W.C. Willett, A. Ascherio, Weight loss in Parkinson’s disease, Ann. Neurol. 53 (2003) 676-679. [2] W.P. Cheshire Jr., Z.K. Wszolek, Body mass index is reduced early in Parkinson’s disease, Park. Relat. Disord. 11 (2005) 35-38.

To cite this abstract in AMA style:

KJ. Pak, HK. Shin, EJ. Kim, JH. Lee, CH. Lyoo, JS. Son, MJ. Lee, HJ. Son. Weight loss is associated with rapid striatal dopaminergic degeneration in Parkinson’s disease [abstract]. Mov Disord. 2018; 33 (suppl 2). https://www.mdsabstracts.org/abstract/weight-loss-is-associated-with-rapid-striatal-dopaminergic-degeneration-in-parkinsons-disease/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/weight-loss-is-associated-with-rapid-striatal-dopaminergic-degeneration-in-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley